抗癌活性肽对胆囊癌GBC-SD细胞作用前后的基因表达谱研究(3)
[8] O’Connor DS，Schechner JS，Adida C，et al.Control of apoptosis during angiogenesis by survivin express in endothelial cell.Am J Pathol，2000，156(2)：393-398.
[9] Rohayem J，Diestelkoetter P，Weigle B，et al.Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cance patients.Cance Res，2000，60(7).
[10] FangJ，Shing Y，WiederschainD，et al.Matrixmetalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.Proc Natl Acad Sci USA，2000，97(8)：3884-3889.
[11] Boulay A，Masson R，Chenard MP，et al.High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin- matrix metalloproteinase.Cancer Res，2001，61(5)：21.
[12] 冯众一，徐惠锦，等.基质金属蛋白酶-2和组织蛋白酶D与胃癌生物学行为及腹膜转移关系.中国肿瘤临床，2002，29(10)：720-722.
[13] Mo FE，Muntean AG，Chen CC，et al.CYR61 (CCN1) is essential for placental development and vascular integrity.Mol Cell Biol，2002，22(24)：8709-8720.
[14] Blobe GC，Schiemann WP，Lodish HF.Role of transforming growth factor in human disease.N Engl J Med，2000，342(18)：1350-1358., http://www.100md.com(云 强 苏秀兰 欧阳晓晖)
[9] Rohayem J，Diestelkoetter P，Weigle B，et al.Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cance patients.Cance Res，2000，60(7).
[10] FangJ，Shing Y，WiederschainD，et al.Matrixmetalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.Proc Natl Acad Sci USA，2000，97(8)：3884-3889.
[11] Boulay A，Masson R，Chenard MP，et al.High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin- matrix metalloproteinase.Cancer Res，2001，61(5)：21.
[12] 冯众一，徐惠锦，等.基质金属蛋白酶-2和组织蛋白酶D与胃癌生物学行为及腹膜转移关系.中国肿瘤临床，2002，29(10)：720-722.
[13] Mo FE，Muntean AG，Chen CC，et al.CYR61 (CCN1) is essential for placental development and vascular integrity.Mol Cell Biol，2002，22(24)：8709-8720.
[14] Blobe GC，Schiemann WP，Lodish HF.Role of transforming growth factor in human disease.N Engl J Med，2000，342(18)：1350-1358., http://www.100md.com(云 强 苏秀兰 欧阳晓晖)